Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1' ligand.

[1]  S. Cen,et al.  Synthesis and biological evaluation of new HIV-1 protease inhibitors with purine bases as P2-ligands. , 2019, Bioorganic & medicinal chemistry letters.

[2]  Arun K. Ghosh,et al.  Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I. , 2019, Biochemical and biophysical research communications.

[3]  Guoning Zhang,et al.  Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands. , 2019, Bioorganic & medicinal chemistry letters.

[4]  Arun K. Ghosh,et al.  Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands. , 2018, European journal of medicinal chemistry.

[5]  Arun K. Ghosh,et al.  Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex. , 2017, Bioorganic & medicinal chemistry.

[6]  Zhiheng Yang,et al.  Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Structure-activity studies and biological evaluation. , 2017, European journal of medicinal chemistry.

[7]  M. Desai,et al.  Synthesis of novel HIV-1 protease inhibitors via diastereoselective Henry reaction with nitrocyclopropane , 2017 .

[8]  Liying Ma,et al.  Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase. , 2017, Bioorganic & medicinal chemistry.

[9]  Santosh Kumar,et al.  Investigational protease inhibitors as antiretroviral therapies , 2016, Expert opinion on investigational drugs.

[10]  Hong-tao Liu,et al.  Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands. , 2015, Bioorganic & medicinal chemistry letters.

[11]  S. Miertus,et al.  Synthesis and biological evaluation of new simple indolic non peptidic HIV Protease inhibitors: the effect of different substitution patterns. , 2014, Bioorganic & medicinal chemistry.

[12]  Guo-Dong Zhao,et al.  Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands. , 2014, Bioorganic & medicinal chemistry letters.

[13]  P. Orth,et al.  Structural optimization of cyclic sulfonamide based novel HIV-1 protease inhibitors to picomolar affinities guided by X-ray crystallographic analysis , 2014 .

[14]  Yong-tang Zheng,et al.  Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. , 2012, Bioorganic & medicinal chemistry letters.

[15]  Cheng-Mei Zhang,et al.  Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands. , 2011, Bioorganic & medicinal chemistry letters.

[16]  Arun K. Ghosh,et al.  Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. , 2010, Bioorganic & medicinal chemistry letters.

[17]  J. Florián,et al.  Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors. , 2007, Journal of molecular biology.

[18]  P A Fernandes,et al.  Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead. , 2007, Journal of molecular graphics & modelling.

[19]  P. Wolschann,et al.  Hydrogen bonding in molecular recognition by HIV-1 protease , 2006 .

[20]  V. Stoll,et al.  Oximinoarylsulfonamides as potent HIV protease inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[21]  L. Vrang,et al.  Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors. , 2010, European journal of medicinal chemistry.

[22]  A Wlodawer,et al.  Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.